Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$5.63M$5.63Mderived+174.3% vs Q4 2019 Net Income$1.30M$1.30MderivedN/M vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$168,298N/M Operating Cash Flowderived-$173,065N/M Free Cash Flowderived-$340,996N/M Margins · derivedOperating margin3.0%+8.5 pt vs Q4 2019
Net margin23.2%+74.0 pt vs Q4 2019
ended Dec 31, 2020 · filed Mar 31, 2021 · 90 d after period end